Which patients discontinue? Issues on Levodopa/carbidopa intestinal gel treatment: Italian multicentre survey of 905 patients with long-term follow-up

Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study

C. Warren Olanow, Karl Kieburtz, Per Odin et al. · The Lancet Neurology · 2013 · 696 citations

Pharmacy, Neurology, Pharmacotherapy +12

Neuropathy and levodopa in Parkinson's disease: Evidence from a multicenter study

Roberto Ceravolo, Giovanni Cossu, M. Poggio et al. · Movement Disorders · 2013 · 156 citations

Medicine, Neurology, Neuroscience +17

Neuropathy in Parkinson disease

Yusuf A. Rajabally, Jean Martey · Neurology · 2011 · 121 citations

Public Health, Neurology, Neuroscience +17

Integrated safety of levodopa‐carbidopa intestinal gel from prospective clinical trials

Anthony E. Lang, Ramon L. Rodriguez, James T. Boyd et al. · Movement Disorders · 2015 · 101 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +10

Long-term response to continuous duodenal infusion of levodopa/carbidopa gel in patients with advanced Parkinson disease: The Barcelona registry

Maríateresa Buongiorno, Francesca Antonelli, Ana Cámara et al. · Parkinsonism & Related Disorders · 2015 · 89 citations

Medicine, Neurology, Pharmacotherapy +10